|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 9/51 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 31/12 | (2006.01) | ||
| A61K 31/4965 | (2006.01) | ||
| A61K 31/5575 | (2006.01) | ||
| A61K 33/00 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2893922 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15150623.5 |
| Date of filing the European patent application | 2015-01-09 | |
| (97) | Date of publication of the European application | 2015-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201400412 | 2014-01-10 | GB |
| (72) |
Yacoub, Magdi , GB
El Sherbiny, Ibrahim , EG
|
| (73) |
Heart Biotech Pharma Limited ,
17 North Drive, Littleton, Winchester SO22 6QA,
GB
|
| (54) | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension |
| Pharmaceutical formulations for the treatment of pulmonary arterial hypertension |